Inflammatory bowel disease in the dog: Differences and similarities with humans

World Journal of Gastroenterology

Volumn 16, Issue 9, 2010, Pages 1050-1056

  Cerquetella, Matteo ^a   Spaterna, Andrea ^a   Laus, Fulvio ^a   Tesei, Beniamino ^a   Rossi, Giacomo ^a   Antonelli, Elisabetta ^b   Villanacci, Vincenzo ^c   Bassotti, Gabrio ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

Colitis; Dog; Inflammatory bowel diseases

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; BUDESONIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOCHROME P450; GAMMA INTERFERON; GLYCOPROTEIN P; HLA ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 5; METRONIDAZOLE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; PATTERN RECOGNITION RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PREBIOTIC AGENT; PREDNISOLONE; PROBIOTIC AGENT; STEROID; SULFOTRANSFERASE 1A1; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY TITER; CELL SUBPOPULATION; CLINICAL FEATURE; COLITIS; CYTOKINE PRODUCTION; DIARRHEA; DOG DISEASE; ECHOGRAPHY; ENTERITIS; GENETIC PREDISPOSITION; HISTIOCYTIC COLITIS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INTESTINE BIOPSY; INTESTINE ENDOSCOPY; LYMPHOCYTIC PLASMACYTIC COLITIS; MACROFOLLICULAR AND DIFFUSE INTERSTITIAL LYMPHOCYTIC COLITIS; MAST CELL; MUCOSAL IMMUNITY; NEUTROPHILIC EOSINOPHILIC COLITIS; NONHUMAN; PLASMA CELL; PROTEIN DIET; PROTEIN EXPRESSION; REVIEW; SPECIES DIFFERENCE; TH1 CELL; TH2 CELL; VOMITING; WEIGHT REDUCTION;

EID: 77949426150     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i9.1050     Document Type: Review

References (85)

1. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009; 296: G135-G146
2. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603
3. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606
4. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, Barakauskiene A, Villanacci V, Von Herbay A, Warren BF, Gasche C, Tilg H, Schreiber SW, Schölmerich J, Reinisch W. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 Suppl 1: i1-i15
5. Stange EF, Travis SPL,Vermeire S, Reinisch W, Geboes K, Barakauskiene A, Feakins R, Fléjou JF, Herfarth H, Hommes DW, Kupcinskas L, Lakatos PL, Mantzaris GJ, Schreiber S, Villanacci V, Warren BF; European Crohn's and Colitis Organisation (ECCO). European evidence-based Consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008; 2: 1-23
6. Cave NJ. Chronic inflammatory disorders of the gastrointestinal tract of companion animals. N Z Vet J 2003; 51: 262-274
7. Washabau RJ, Holt DE. Diseases of the large intestine. In: Ettinger SJ, Feldman EC, editors. Textbook of Veterinary Internal Medicine. 6th ed. St. Louis: Elsevier-Saunders, 2005: 1378-1407
8. Kleinschmidt S, Meneses F, Nolte I, Hewicker-Trautwein M. Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocyticplasmacytic or eosinophilic gastroenterocolitis. Vet Immunol Immunopathol 2007; 120: 80-92
9. Schreiner NM, Gaschen F, Gröne A, Sauter SN, Allenspach K. Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies. J Vet Intern Med 2008; 22: 1079-1083
10. Hall EJ, German AJ. Malattia infiammatoria intestinale. In: Steiner JM, editor. Gastroenterologia del cane e del gatto. Milano: Elsevier, 2009: 296-311
11. German AJ, Hall EJ, Day MJ. Chronic intestinal inflammation and intestinal disease in dogs. J Vet Intern Med 2003; 17: 8-20
12. Zoran DL. Fisiopatologia e trattamento delle colopatie nel cane. Suppl Veterinaria 2001; 15: 19-30
13. Scherding RG. Diseases of the large intestine. In: Tams TR, editor. Handbook of Small Animal Gastroenterology. 2nd ed. St. Louis: Saunders, 2003: 251-285
14. Jergens AE, Zoran DL. Diseases of the colon and rectum. In: Hall EJ, Simpson JW, Williams DA, editors. BSAVA Manual of Canine and Feline Gastroenterology, 2nd edition. Gloucester: British Small Animal Veterinary Association, 2005: 203-212
15. Willard MD. Patologie dell'apparato digerente. In: Nelson RW, Couto CG, editors. Medicina interna del cane e del gatto. 3rd ed. Milano: Elsevier Masson, 2007: 255-482
16. Leib MS. Il grosso intestino. In: Steiner JM, editor. Gastroenterologia del cane e del gatto. Milano: Elsevier, 2009: 205-212
17. Davies DR, O'Hara AJ, Irwin PJ, Guilford WG. Successful management of histiocytic ulcerative colitis with enrofloxacin in two Boxer dogs. Aust Vet J 2004; 82: 58-61
18. Stokes JE, Kruger JM, Mullaney T, Holan K, Schall W. Histiocytic ulcerative colitis in three non-boxer dogs. J Am Anim Hosp Assoc 2001; 37: 461-465
19. Luckschander N, Allenspach K, Hall J, Seibold F, Gröne A, Doherr MG, Gaschen F. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. J Vet Intern Med 2006; 20: 221-227
20. Locher C, Tipold A, Welle M, Busato A, Zurbriggen A, Griot-Wenk ME. Quantitative assessment of mast cells and expression of IgE protein and mRNA for IgE and interleukin 4 in the gastrointestinal tract of healthy dogs and dogs with inflammatory bowel disease. Am J Vet Res 2001; 62: 211-216
21. Greger DL, Gropp F, Morel C, Sauter S, Blum JW. Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies. Domest Anim Endocrinol 2006; 31: 327-339
22. Dandrieux JR, Bornand VF, Doherr MG, Kano R, Zurbriggen A, Burgener IA. Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease. Am J Vet Res 2008; 69: 1279-1285
23. Luckschander N, Hall JA, Gaschen F, Forster U, Wenzlow N, Hermann P, Allenspach K, Dobbelaere D, Burgener IA, Welle M. Activation of nuclear factor-kappaB in dogs with chronic enteropathies. Vet Immunol Immunopathol 2010; 133: 228-236
24. Hall EJ, German AJ. Diseases of the small intestine. In: Ettinger SJ, Feldman EC, editors. Textbook of Veterinary Internal Medicine. 6th ed. St. Louis: Elsevier Saunders, 2005: 1332-1378
25. Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology 2008; 125: 145-153
26. Burgener IA, König A, Allenspach K, Sauter SN, Boisclair J, Doherr MG, Jungi TW. Upregulation of toll-like receptors in chronic enteropathies in dogs. J Vet Intern Med 2008; 22: 553-560
27. Bauer S, Müller T, Hamm S. Pattern recognition by Toll-like receptors. Adv Exp Med Biol 2009; 653: 15-34
28. Tanaka K. Expression of Toll-like receptors in the intestinal mucosa of patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2008; 2: 193-196
29. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53: 685-693
30. Takaishi H, Matsuki T, Nakazawa A, Takada T, Kado S, Asahara T, Kamada N, Sakuraba A, Yajima T, Higuchi H, Inoue N, Ogata H, Iwao Y, Nomoto K, Tanaka R, Hibi T. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 2008; 298: 463-472
31. Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol Ecol 2008; 66: 579-589
32. German AJ, Bland PW, Hall EJ, Day MJ. Expression of major histocompatibility complex class II antigens in the canine intestine. Vet Immunol Immunopathol 1998; 61: 171-180
33. German AJ, Hall EJ, Day MJ. Analysis of leucocyte subsets in the canine intestine. J Comp Pathol 1999; 120: 129-145
34. German AJ, Helps CR, Hall EJ, Day MJ. Cytokine mRNA expression in mucosal biopsies from German shepherd dogs with small intestinal enteropathies. Dig Dis Sci 2000; 45: 7-17
35. Peters IR, Helps CR, Calvert EL, Hall EJ, Day MJ. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. J Vet Intern Med 2005; 19: 644-653
36. Jergens AE, Sonea IM, O'Connor AM, Kauffman LK, Grozdanic SD, Ackermann MR, Evans RB. Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. Comp Med 2009; 59: 153-162
37. Allenspach K, Bergman PJ, Sauter S, Gröne A, Doherr MG, Gaschen F. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. J Comp Pathol 2006; 134: 1-7
38. German AJ, Hall EJ, Day MJ. Immune cell populations within the duodenal mucosa of dogs with enteropathies. J Vet Intern Med 2001; 15: 14-25
39. Wu GD. Is there a role for PPAR gamma in IBD? Yes, no, maybe. Gastroenterology 2003; 124: 1538-1542
40. Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P. PPAR-gamma as a new therapeutic target in inflammatory bowel diseases. Gut 2006; 55: 1341-1349
41. Noomen CG, Hommes DW, Fidder HH. Update on genetics in inflammatory disease. Best Pract Res Clin Gastroenterol 2009; 23: 233-243
42. Achkar JP, Fiocchi C. Gene-gene interactions in inflammatory bowel disease: biological and clinical implications. Am J Gastroenterol 2009; 104: 1734-1736
43. Ishihara S, Aziz MM, Yuki T, Kazumori H, Kinoshita Y. Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol 2009; 44: 1097-1108
44. Mendoza JL, Lana R, Diaz-Rubio M, de la Concha EG, Urcelay E. Pharmacogenetics of therapy in inflammatory bowel disease patients. Curr Pharmacogenomics 2007; 5: 235-247
45. Lakatos PL. Environmental factors affecting inflammatory bowel disease: have we made progress? Dig Dis 2009; 27: 215-225
46. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008; 263: 597-606
47. Chichlowski M, Hale LP. Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad. Am J Physiol Gastrointest Liver Physiol 2008; 295: G1139-G1149
48. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15: 1528-1536
49. Andoh A, Benno Y, Kanauchi O, Fujiyama Y. Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15: 2066-2073
50. Perencevich M, Burakoff R. Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 651-664
51. Rubin DT, Kornblunth A. Role of antibiotics in the management of inflammatory bowel disease: a review. Rev Gastroenterol Disord 2005; 5 Suppl 3: S10-S15
52. Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep 2007; 9: 497-507
53. Neurath MF, Finotto S, Fuss I, Boirivant M, Galle PR, Strober W. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol 2001; 22: 21-26
54. Nikoopour E, Schwartz JA, Singh B. Therapeutic benefits of regulating inflammation in autoimmunity. Inflamm Allergy Drug Targets 2008; 7: 203-210
55. Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med 2008; 263: 591-596
56. Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1090-1100
57. José León A, Garrote JA, Arranz E. [Cytokines in the pathogenesis of inflammatory bowel diseases] Med Clin (Barc) 2006; 127: 145-152
58. Sturgess K. Diagnosis and management of idiopathic inflammatory bowel disease in dogs and cats. In Practice 2005; 27: 291-301
59. Tams TR. Chronic diseases of the small intestine. In: Tams TR, editor. Handbook of Small Animal Gastroenterology. 2nd ed. St. Louis: Saunders, 2003: 211-250
60. Rychlik A, Nieradka R, Kander M, Depta A, Nowicki M, Sarti K. Usefulness of endoscopic examination for the diagnosis of inflammatory bowel disease in the dog. Pol J Vet Sci 2007; 10: 113-118
61. Penninck D, Smyers B, Webster CR, Rand W, Moore AS. Diagnostic value of ultrasonography in differentiating enteritis from intestinal neoplasia in dogs. Vet Radiol Ultrasound 2003; 44: 570-575
62. Gaschen L. The role of imaging in dogs and cats with vomiting and chronic diarrhoea. 11th FECAVA Congress. The Netherlands: EJCAP, 2005: 15197-15203
63. Gaschen L, Kircher P. Two-dimensional grayscale ultrasound and spectral Doppler waveform evaluation of dogs with chronic enteropathies. Clin Tech Small Anim Pract 2007; 22: 122-127
64. Schreiner NM, Gaschen F, Gröne A, Sauter SN, Allenspach K. Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies. J Vet Intern Med 2008; 22: 1079-1083
65. Day MJ, Bilzer T, Mansell J, Wilcock B, Hall EJ, Jergens A, Minami T, Willard M, Washabau R. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. J Comp Pathol 2008; 138 Suppl 1: S1-S43
66. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008; 103: 162-169
67. Li X, Conklin L, Alex P. New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 2008; 14: 5115-5124
68. Barahona-Garrido J, Sarti HM, Barahona-Garrido MK, Hernández-Calleros J, Coss-Adame E, Garcia-Saenz SM, Yamamoto-Furusho JK. Serological markers in inflammatory bowel disease: a review of their clinical utility. Rev Gastroenterol Mex 2009; 74: 230-237
69. Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F. Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease. Am J Vet Res 2004; 65: 1279-1283
70. Kobayashi S, Ohno K, Uetsuka K, Nakashima K, Setoguchi A, Fujino Y, Tsujimoto H. Measurement of intestinal mucosal permeability in dogs with lymphocytic-plasmacytic enteritis. J Vet Med Sci 2007; 69: 745-749
71. Suchodolski JS, Steiner JM. Laboratory assessment of gastrointestinal function. Clin Tech Small Anim Pract 2003; 18: 203-210
72. Gunawardana SC, Jergens AE, Ahrens FA, Niyo Y. Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease. J Am Vet Med Assoc 1997; 211: 318-321
73. McCann TM, Ridyard AE, Else RW, Simpson JW. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease. J Small Anim Pract 2007; 48: 620-625
74. Loftus EV Jr. Clinical perspectives in Crohn's disease. Objective measures of disease activity: alternatives to symptom indices. Rev Gastroenterol Disord 2007; 7 Suppl 2: S8-S16
75. Jergens AE, Schreiner CA, Frank DE, Niyo Y, Ahrens FE, Eckersall PD, Benson TJ, Evans R. A scoring index for disease activity in canine inflammatory bowel disease. J Vet Intern Med 2003; 17: 291-297
76. Jergens AE. Clinical assessment of disease activity for canine inflammatory bowel disease. J Am Anim Hosp Assoc 2004; 40: 437-445
77. Allenspach K, Wieland B, Gröne A, Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. J Vet Intern Med 2007; 21: 700-708
78. Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J Small Anim Pract 2004; 45: 336-342
79. Allenspach K. Tests to investigate gastrointestinal diseases in dogs - which markers are actually useful for the practitioner? J Small Anim Pract 2007; 48: 607-608
80. Kathrani A, Steiner JM, Suchodolski J, Eastwood J, Syme H, Garden OA, Allenspach K. Elevated canine pancreatic lipase immunoreactivity concentration in dogs with inflammatory bowel disease is associated with a negative outcome. J Small Anim Pract 2009; 50: 126-132
81. Bosani M, Ardizzone S, Porro GB. Biologic targeting in the treatment of inflammatory bowel diseases. Biologics 2009; 3: 77-97
82. Spichiger AC, Allenspach K, Ontsouka E, Gaschen F, Morel C, Blum JW, Sauter SN. Abundance of mRNA of growth hormone receptor and insulin-like growth factors-1 and -2 in duodenal and colonic biopsies of dogs with chronic enteropathies*. J Vet Med A Physiol Pathol Clin Med 2005; 52: 491-497
83. Cerquetella M, Spaterna A. Malattia infiammatoria cronica intestinale nel cane possibile modello di studio comparativo nell'uomo? Il Gastroenterologo 2007; 4: 88-92
84. Qin X. What is human inflammatory bowel disease (IBD) more like: Johne's disease in cattle or IBD in dogs and cats? Inflamm Bowel Dis 2008; 14: 138
85. Wehkamp J, Stange EF. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 2006; 1072: 321-331